Scars clinical trials

Explore recruiting scars clinical trials.

Recruiting scars studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Scars trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Immediate post-surgical Botulinum toxin injections to prevent dystrophic Scars after sternotomy : a placebo-controlled randomized clinical trial - BotuCiSter

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase II, prospective, intra-patient randomised controlled, multicentre study to evaluate the safety and efficacy of an autologous bio-engineered dermo-epidermal skin substitute (EHSG-KF) for the treatment of full thickness skin defects in adults and children in comparison to autologous split-thickness skin grafts (STSG) (RAC)

Italy, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Randomized clinical trial to compare oral isotretinoin to standard of care in moderate acne skin of color patients

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy and safety of repeated Rituximab infusions in patients with Active Systemic SClerosis and background medication, a one year randomized blinded placebo-controlled trial, the RASSc study.

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

European Randomised Clinical Trial on mPOX Infection (EPOXI)

Netherlands, France, Portugal, Germany, Belgium, Spain +2 more

Therapeutic use (Phase IV) EU CTIS Study details

Scars trials by city

Scars in Toronto Scars in Vancouver Scars in Montreal Scars in Calgary Scars in Edmonton Scars in Ottawa Scars in Winnipeg Scars in Quebec City Scars in Hamilton Scars in Kitchener Scars in London Scars in Halifax Scars in New York Scars in Los Angeles Scars in Chicago Scars in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease